Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells

Standard

Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells. / Witkowski, Mario; Tizian, Caroline; Ferreira-Gomes, Marta; Niemeyer, Daniela; Jones, Terry C; Heinrich, Frederik; Frischbutter, Stefan; Angermair, Stefan; Hohnstein, Thordis; Mattiola, Irene; Nawrath, Philipp; McEwen, Sophie; Zocche, Silvia; Viviano, Edoardo; Heinz, Gitta Anne; Maurer, Marcus; Kölsch, Uwe; Chua, Robert Lorenz; Aschman, Tom; Meisel, Christian; Radke, Josefine; Sawitzki, Birgit; Roehmel, Jobst; Allers, Kristina; Moos, Verena; Schneider, Thomas; Hanitsch, Leif; Mall, Marcus A; Conrad, Christian; Radbruch, Helena; Duerr, Claudia U; Trapani, Joseph A; Marcenaro, Emanuela; Kallinich, Tilmann; Corman, Victor M; Kurth, Florian; Sander, Leif Erik; Drosten, Christian; Treskatsch, Sascha; Durek, Pawel; Kruglov, Andrey; Radbruch, Andreas; Mashreghi, Mir-Farzin; Diefenbach, Andreas.

in: NATURE, Jahrgang 600, Nr. 7888, 12.2021, S. 295-301.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Witkowski, M, Tizian, C, Ferreira-Gomes, M, Niemeyer, D, Jones, TC, Heinrich, F, Frischbutter, S, Angermair, S, Hohnstein, T, Mattiola, I, Nawrath, P, McEwen, S, Zocche, S, Viviano, E, Heinz, GA, Maurer, M, Kölsch, U, Chua, RL, Aschman, T, Meisel, C, Radke, J, Sawitzki, B, Roehmel, J, Allers, K, Moos, V, Schneider, T, Hanitsch, L, Mall, MA, Conrad, C, Radbruch, H, Duerr, CU, Trapani, JA, Marcenaro, E, Kallinich, T, Corman, VM, Kurth, F, Sander, LE, Drosten, C, Treskatsch, S, Durek, P, Kruglov, A, Radbruch, A, Mashreghi, M-F & Diefenbach, A 2021, 'Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells', NATURE, Jg. 600, Nr. 7888, S. 295-301. https://doi.org/10.1038/s41586-021-04142-6

APA

Witkowski, M., Tizian, C., Ferreira-Gomes, M., Niemeyer, D., Jones, T. C., Heinrich, F., Frischbutter, S., Angermair, S., Hohnstein, T., Mattiola, I., Nawrath, P., McEwen, S., Zocche, S., Viviano, E., Heinz, G. A., Maurer, M., Kölsch, U., Chua, R. L., Aschman, T., ... Diefenbach, A. (2021). Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells. NATURE, 600(7888), 295-301. https://doi.org/10.1038/s41586-021-04142-6

Vancouver

Witkowski M, Tizian C, Ferreira-Gomes M, Niemeyer D, Jones TC, Heinrich F et al. Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells. NATURE. 2021 Dez;600(7888):295-301. https://doi.org/10.1038/s41586-021-04142-6

Bibtex

@article{3d5dc7879c4d43a181fcae01183be611,
title = "Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells",
abstract = "SARS-CoV-2 is a single-stranded RNA virus that causes COVID-19. Given its acute and often self-limiting course, it is likely that components of the innate immune system play a central part in controlling virus replication and determining clinical outcome. Natural killer (NK) cells are innate lymphocytes with notable activity against a broad range of viruses, including RNA viruses1,2. NK cell function may be altered during COVID-19 despite increased representation of NK cells with an activated and adaptive phenotype3,4. Here we show that a decline in viral load in COVID-19 correlates with NK cell status and that NK cells can control SARS-CoV-2 replication by recognizing infected target cells. In severe COVID-19, NK cells show defects in virus control, cytokine production and cell-mediated cytotoxicity despite high expression of cytotoxic effector molecules. Single-cell RNA sequencing of NK cells over the time course of the COVID-19 disease spectrum reveals a distinct gene expression signature. Transcriptional networks of interferon-driven NK cell activation are superimposed by a dominant transforming growth factor-β (TGFβ) response signature, with reduced expression of genes related to cell-cell adhesion, granule exocytosis and cell-mediated cytotoxicity. In severe COVID-19, serum levels of TGFβ peak during the first two weeks of infection, and serum obtained from these patients severely inhibits NK cell function in a TGFβ-dependent manner. Our data reveal that an untimely production of TGFβ is a hallmark of severe COVID-19 and may inhibit NK cell function and early control of the virus.",
keywords = "Atlases as Topic, COVID-19/immunology, Gene Expression Regulation/immunology, Humans, Immunity, Innate, Influenza, Human/immunology, Killer Cells, Natural/immunology, RNA-Seq, SARS-CoV-2/immunology, Single-Cell Analysis, Time Factors, Transforming Growth Factor beta/blood, Viral Load/immunology, Virus Replication/immunology",
author = "Mario Witkowski and Caroline Tizian and Marta Ferreira-Gomes and Daniela Niemeyer and Jones, {Terry C} and Frederik Heinrich and Stefan Frischbutter and Stefan Angermair and Thordis Hohnstein and Irene Mattiola and Philipp Nawrath and Sophie McEwen and Silvia Zocche and Edoardo Viviano and Heinz, {Gitta Anne} and Marcus Maurer and Uwe K{\"o}lsch and Chua, {Robert Lorenz} and Tom Aschman and Christian Meisel and Josefine Radke and Birgit Sawitzki and Jobst Roehmel and Kristina Allers and Verena Moos and Thomas Schneider and Leif Hanitsch and Mall, {Marcus A} and Christian Conrad and Helena Radbruch and Duerr, {Claudia U} and Trapani, {Joseph A} and Emanuela Marcenaro and Tilmann Kallinich and Corman, {Victor M} and Florian Kurth and Sander, {Leif Erik} and Christian Drosten and Sascha Treskatsch and Pawel Durek and Andrey Kruglov and Andreas Radbruch and Mir-Farzin Mashreghi and Andreas Diefenbach",
note = "{\textcopyright} 2021. The Author(s), under exclusive licence to Springer Nature Limited.",
year = "2021",
month = dec,
doi = "10.1038/s41586-021-04142-6",
language = "English",
volume = "600",
pages = "295--301",
journal = "NATURE",
issn = "0028-0836",
publisher = "NATURE PUBLISHING GROUP",
number = "7888",

}

RIS

TY - JOUR

T1 - Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells

AU - Witkowski, Mario

AU - Tizian, Caroline

AU - Ferreira-Gomes, Marta

AU - Niemeyer, Daniela

AU - Jones, Terry C

AU - Heinrich, Frederik

AU - Frischbutter, Stefan

AU - Angermair, Stefan

AU - Hohnstein, Thordis

AU - Mattiola, Irene

AU - Nawrath, Philipp

AU - McEwen, Sophie

AU - Zocche, Silvia

AU - Viviano, Edoardo

AU - Heinz, Gitta Anne

AU - Maurer, Marcus

AU - Kölsch, Uwe

AU - Chua, Robert Lorenz

AU - Aschman, Tom

AU - Meisel, Christian

AU - Radke, Josefine

AU - Sawitzki, Birgit

AU - Roehmel, Jobst

AU - Allers, Kristina

AU - Moos, Verena

AU - Schneider, Thomas

AU - Hanitsch, Leif

AU - Mall, Marcus A

AU - Conrad, Christian

AU - Radbruch, Helena

AU - Duerr, Claudia U

AU - Trapani, Joseph A

AU - Marcenaro, Emanuela

AU - Kallinich, Tilmann

AU - Corman, Victor M

AU - Kurth, Florian

AU - Sander, Leif Erik

AU - Drosten, Christian

AU - Treskatsch, Sascha

AU - Durek, Pawel

AU - Kruglov, Andrey

AU - Radbruch, Andreas

AU - Mashreghi, Mir-Farzin

AU - Diefenbach, Andreas

N1 - © 2021. The Author(s), under exclusive licence to Springer Nature Limited.

PY - 2021/12

Y1 - 2021/12

N2 - SARS-CoV-2 is a single-stranded RNA virus that causes COVID-19. Given its acute and often self-limiting course, it is likely that components of the innate immune system play a central part in controlling virus replication and determining clinical outcome. Natural killer (NK) cells are innate lymphocytes with notable activity against a broad range of viruses, including RNA viruses1,2. NK cell function may be altered during COVID-19 despite increased representation of NK cells with an activated and adaptive phenotype3,4. Here we show that a decline in viral load in COVID-19 correlates with NK cell status and that NK cells can control SARS-CoV-2 replication by recognizing infected target cells. In severe COVID-19, NK cells show defects in virus control, cytokine production and cell-mediated cytotoxicity despite high expression of cytotoxic effector molecules. Single-cell RNA sequencing of NK cells over the time course of the COVID-19 disease spectrum reveals a distinct gene expression signature. Transcriptional networks of interferon-driven NK cell activation are superimposed by a dominant transforming growth factor-β (TGFβ) response signature, with reduced expression of genes related to cell-cell adhesion, granule exocytosis and cell-mediated cytotoxicity. In severe COVID-19, serum levels of TGFβ peak during the first two weeks of infection, and serum obtained from these patients severely inhibits NK cell function in a TGFβ-dependent manner. Our data reveal that an untimely production of TGFβ is a hallmark of severe COVID-19 and may inhibit NK cell function and early control of the virus.

AB - SARS-CoV-2 is a single-stranded RNA virus that causes COVID-19. Given its acute and often self-limiting course, it is likely that components of the innate immune system play a central part in controlling virus replication and determining clinical outcome. Natural killer (NK) cells are innate lymphocytes with notable activity against a broad range of viruses, including RNA viruses1,2. NK cell function may be altered during COVID-19 despite increased representation of NK cells with an activated and adaptive phenotype3,4. Here we show that a decline in viral load in COVID-19 correlates with NK cell status and that NK cells can control SARS-CoV-2 replication by recognizing infected target cells. In severe COVID-19, NK cells show defects in virus control, cytokine production and cell-mediated cytotoxicity despite high expression of cytotoxic effector molecules. Single-cell RNA sequencing of NK cells over the time course of the COVID-19 disease spectrum reveals a distinct gene expression signature. Transcriptional networks of interferon-driven NK cell activation are superimposed by a dominant transforming growth factor-β (TGFβ) response signature, with reduced expression of genes related to cell-cell adhesion, granule exocytosis and cell-mediated cytotoxicity. In severe COVID-19, serum levels of TGFβ peak during the first two weeks of infection, and serum obtained from these patients severely inhibits NK cell function in a TGFβ-dependent manner. Our data reveal that an untimely production of TGFβ is a hallmark of severe COVID-19 and may inhibit NK cell function and early control of the virus.

KW - Atlases as Topic

KW - COVID-19/immunology

KW - Gene Expression Regulation/immunology

KW - Humans

KW - Immunity, Innate

KW - Influenza, Human/immunology

KW - Killer Cells, Natural/immunology

KW - RNA-Seq

KW - SARS-CoV-2/immunology

KW - Single-Cell Analysis

KW - Time Factors

KW - Transforming Growth Factor beta/blood

KW - Viral Load/immunology

KW - Virus Replication/immunology

U2 - 10.1038/s41586-021-04142-6

DO - 10.1038/s41586-021-04142-6

M3 - SCORING: Journal article

C2 - 34695836

VL - 600

SP - 295

EP - 301

JO - NATURE

JF - NATURE

SN - 0028-0836

IS - 7888

ER -